Ellingson BM, Wen PY, Chang SM, van den Bent M, et al. Objective response rate (ORR) targets for recurrent glioblastoma clinical trials based on the historic association between ORR and median overall survival. Neuro Oncol 2023 Jan 7:noad002. doi: 10.1093.
PMID: 36617262